C. Marosi

420 total citations
19 papers, 325 citations indexed

About

C. Marosi is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, C. Marosi has authored 19 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Genetics and 4 papers in Surgery. Recurrent topics in C. Marosi's work include Glioma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). C. Marosi is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). C. Marosi collaborates with scholars based in Austria, Switzerland and Germany. C. Marosi's co-authors include Christian Gläser, Thomas Leitha, M. Pruckmayer, Hendrati Pirc‐Danoewinata, Peter Bettelheim, M. Rasse, Stephan Lang, W. Millesi, R. Jakesz and Gerhard Kreiner and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. Marosi

19 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Marosi Austria 8 126 82 72 64 62 19 325
Chandrika N. Nair India 13 94 0.7× 107 1.3× 19 0.3× 191 3.0× 117 1.9× 34 435
John Norman Australia 10 208 1.7× 273 3.3× 38 0.5× 23 0.4× 56 0.9× 23 512
Humayun Islam United States 10 144 1.1× 35 0.4× 17 0.2× 28 0.4× 70 1.1× 33 330
Sheila M. Dobin United States 12 76 0.6× 38 0.5× 45 0.6× 266 4.2× 50 0.8× 36 442
Francesco Pietrogrande Italy 11 174 1.4× 88 1.1× 13 0.2× 35 0.5× 16 0.3× 21 352
Avery A. Sandberg United States 10 65 0.5× 40 0.5× 28 0.4× 164 2.6× 22 0.4× 13 408
Antoinette B. Thomas United States 8 64 0.5× 27 0.3× 21 0.3× 91 1.4× 80 1.3× 18 289
Emad Raddaoui Saudi Arabia 9 74 0.6× 23 0.3× 23 0.3× 158 2.5× 78 1.3× 29 402
Sabrina Aliberti Italy 11 84 0.7× 51 0.6× 10 0.1× 31 0.5× 55 0.9× 19 293
Gianfranco Recher Italy 15 276 2.2× 23 0.3× 52 0.7× 176 2.8× 195 3.1× 35 560

Countries citing papers authored by C. Marosi

Since Specialization
Citations

This map shows the geographic impact of C. Marosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Marosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Marosi more than expected).

Fields of papers citing papers by C. Marosi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Marosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Marosi. The network helps show where C. Marosi may publish in the future.

Co-authorship network of co-authors of C. Marosi

This figure shows the co-authorship network connecting the top 25 collaborators of C. Marosi. A scholar is included among the top collaborators of C. Marosi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Marosi. C. Marosi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Preusser, Matthias, Adelheid Wöehrer, N. Zielonke, et al.. (2011). Real-life survival in unselected adult glioblastoma patients: A population-based study.. Journal of Clinical Oncology. 29(15_suppl). 2014–2014. 2 indexed citations
2.
Strik, Herwig, Hans Christoph Bock, & C. Marosi. (2011). Use of Tegwondo, a near-continuous temozolomide regimen, in high- and low-grade gliomas.. Journal of Clinical Oncology. 29(15_suppl). 2084–2084. 1 indexed citations
3.
Elandt, Katarzyna, Matthias Preusser, Karin Dieckmann, et al.. (2010). Treatment with bevazicumab and liposomal doxorubicin for recurrent high-grade gliomas (HGGs).. Journal of Clinical Oncology. 28(15_suppl). e12522–e12522. 1 indexed citations
4.
Elandt, Katarzyna, et al.. (2008). Severe thrombocytopenia after the first cycle of temozolomide: Who is at risk?. Journal of Clinical Oncology. 26(15_suppl). 13019–13019. 1 indexed citations
5.
Strik, Herwig, Jan Hendrik Buhk, Cathryn H. Bock, et al.. (2008). Tegwondo: Development of a novel near-continuous dose-dense temozolomide regimen for the treatment of recurrent brain tumors. Journal of Clinical Oncology. 26(15_suppl). 13016–13016. 7 indexed citations
6.
Fazeny-Dörner, Barbara, C. Wenzel, Andrea Berzlanovich, et al.. (2003). Central venous catheter pinch-off and fracture: recognition, prevention and management. Bone Marrow Transplantation. 31(10). 927–930. 37 indexed citations
7.
Crevenna, Richard, Manuela Schmidinger, Mohammad Kéilani, et al.. (2002). Aerobic exercise for breast cancer patients receiving adjuvant oncological treatment - results of the first Austrian outpatient training group. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. 12(2). 102–102. 6 indexed citations
8.
Pruckmayer, M., Christian Gläser, C. Marosi, & Thomas Leitha. (1998). Mandibular pain as the leading clinical symptom for metastatic disease: Nine cases and review of the literature. Annals of Oncology. 9(5). 559–564. 42 indexed citations
9.
Gläser, Christian, Stephan Lang, M. Pruckmayer, et al.. (1997). Clinical manifestations and diagnostic approach to metastatic cancer of the mandible. International Journal of Oral and Maxillofacial Surgery. 26(5). 365–368. 54 indexed citations
10.
Pirc‐Danoewinata, Hendrati, et al.. (1996). Cytogenetic findings in colorectal cancer mirror multistep evolution of colorectal cancer.. PubMed. 108(23). 752–8. 1 indexed citations
11.
Korpan, M., Alexandra C. Budinsky, Michael Binder, et al.. (1996). Impaired hemorheology in patients with postmastectomy lymphedema. Breast Cancer Research and Treatment. 38(3). 283–288. 2 indexed citations
12.
Fiegl, Michael, Thomas Schenk, R. Jakesz, et al.. (1995). Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. British Journal of Cancer. 72(1). 51–55. 42 indexed citations
13.
Pirc‐Danoewinata, Hendrati, Michael Kundi, Ernst Schlögl, et al.. (1995). Phorbol-12,13-dibutyrate improves the quality of cytogenetic preparation in lymphoid malignancies. Cancer Genetics and Cytogenetics. 80(2). 129–134. 4 indexed citations
14.
Mader, Robert M., et al.. (1994). Double modulation of 5-fluorouracil by high-dose leucovorin and interferon?2b in advanced colorectal cancer. Journal of Cancer Research and Clinical Oncology. 120(5). 314–318. 4 indexed citations
15.
Steger, G.G., et al.. (1993). GM‐CSF in the treatment of a patient with severe methotrexate intoxication. Journal of Internal Medicine. 233(6). 499–502. 9 indexed citations
16.
Marosi, C., Peter Bettelheim, Andreas Chott, et al.. (1992). Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia. Annals of Hematology. 64(2). 101–104. 16 indexed citations
17.
Marosi, C., Ursula Köller, Ilse Schwarzinger, et al.. (1992). Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genetics and Cytogenetics. 61(1). 14–25. 55 indexed citations
18.
Schlappack, O., L Havelec, Robert M. Mader, et al.. (1991). [5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma].. PubMed. 103(11). 332–9. 1 indexed citations
19.
Marosi, C., et al.. (1990). Fatal encephalitis in a patient with chronic graft-versus-host disease.. PubMed. 6(1). 53–7. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandrika N. Nair Breakdown of academic impact, for papers by John Norman Breakdown of academic impact, for papers by Humayun Islam Breakdown of academic impact, for papers by Sheila M. Dobin Breakdown of academic impact, for papers by Francesco Pietrogrande Breakdown of academic impact, for papers by Avery A. Sandberg Breakdown of academic impact, for papers by Antoinette B. Thomas Breakdown of academic impact, for papers by Emad Raddaoui Breakdown of academic impact, for papers by Sabrina Aliberti Breakdown of academic impact, for papers by Gianfranco Recher
Rankless by CCL
2026